Related Articles
Follicular Lymphoma Treatment: What’s the Latest? | Dana-Farber Cancer Institute
Follicular lymphoma is a slow-growing form of non-Hodgkin lymphoma (NHL) that arises in white blood cells called B lymphocytes.
Boston Marathon Run is Mother-Daughter Moment for Breast and Uterine Cancer Survivor | Dana-Farber Cancer Institute
Published: April 12, 2024Written by: Saul WisniaRunners call it Heartbreak Hill, but for Michelle O’Brien the long, rising stretch of pavement that crosses the 20-mile…
BCL2 Inhibitors: What’s the Latest Research? | Dana-Farber Cancer Institute
BCL2 inhibitors are drugs that prompt cancer cells to die by altering the interactions among key proteins within the cells.
A Patient-Doctor Bond Forged in Fighting Follicular Lymphoma | Dana-Farber Cancer Institute
Along with his wife, Lorna, one individual has been there for Robert Jenkins nearly every step of the way: his oncologist Eric Jacobsen, MD.
New England
The North American Neuroendocrine Tumor Society (NANETS) offers comprehensive, accredited medical education programs on NET disease that are developed by leading NET experts and designed…
Patient with Breast Cancer Lives Her Best Life with the Help of a Team | Dana-Farber Cancer Institute
Dana-Farber’s Program for Older Adults with Breast Cancer was created for patients like Vici Robinson to ensure that they can live fulfilling lives.
Still Swimming with Sharks After Inflammatory Breast Cancer | Dana-Farber Cancer Institute
As a veteran scuba diver who has donned her wetsuit around the globe, Stephanie Lafontaine is never more at peace than when deep below the…
Fox Chase Cancer Center Recognizes Nobel Laureate Dr. William Kaelin With the Stanley P. Reimann Honor Award
PHILADELPHIA (April 4, 2024)—William Kaelin Jr., MD, physician, scientist, and Nobel laureate, was recognized today at Fox Chase Cancer Center with the Stanley P. Reimann…
Palliative care leader receives prestigious ASCO Special Award | Dana-Farber Cancer Institute
The American Society of Clinical Oncology (ASCO) recognized Janet L. Abrahm, MD, FACP, FAAHPM, of Dana-Farber Cancer Institute and Brigham and Women’s Hospital, as a…
How Treatment Works for CAR T-Cell Therapy Patients | Dana-Farber Cancer Institute
CAR T-cell therapy is a form of immunotherapy that uses specially modified T cells — part of the body’s defense system against disease — to…